2007•Zhongguo yaofangRequires access

Reduced Glutathione for Chronic Liver Disease: Observation of Curative Efficacy

Cao Huiqin

Abstract

OBJECTIVE: To observe the curative effect and safety of Reduced Glutathione in treating chronic liver disease. METHODS: A total of 126 patients with chronic liver disease were randomized to receive Reduced Glutathione( trial group) and Potassium Magnessium Aspartape( control group) for 3wk. The primary end points were liver function and change of clinical symptoms. RESULTS: The trial group showed significant improvement in liver function and clinical symptoms after 3- week treatment( P0. 05) , which was better than in control group( P0. 01) . CONCLUSION: Reduced glutathione can improve the liver function in patients with chronic liver.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Glutathione, Medicine, Internal medicine, Liver function, Chronic liver disease, Gastroenterology, Clinical trial, Liver function tests